3,521 results match your criteria EuroIntervention Journal [Journal]


Significant association among residual SYNTAX score, non-culprit major adverse cardiac events, and grayscale and virtual histology intravascular ultrasound findings: a substudy from PROSPECT.

EuroIntervention 2018 Dec 18. Epub 2018 Dec 18.

Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.

Aims: Residual SYNTAX score (rSS) is known to be associated with cardiac events. We sought to investigate the association between rSS and grayscale and virtual histology (VH)-intravascular ultrasound (IVUS) plaque morphology, and the association between rSS and non-culprit-related major adverse cardiac events (MACE) using data from the PROSPECT study.

Methods And Results: A total of 697 patients with acute coronary syndromes were enrolled in the PROSPECT study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00681DOI Listing
December 2018

Long-term results and durability of the CoreValve transcatheter aortic bioprosthesis: outcomes beyond five years.

EuroIntervention 2018 Dec 18. Epub 2018 Dec 18.

Vascular and CardioThoracic Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

Aims: to determine long-term outcomes of high-risk patients who underwent transcatheter aortic valve implantation (TAVI) with third-generation CoreValve device, according to the 2017 EAPCI/ESC/EACTS definition of valve durability.

Methods And Results: between 2007 and 2013, 278 consecutive patients were enrolled in our prospective single-centre CoreValve registry (mean age 82±6 years, mean STS score 6.4±5. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00779DOI Listing
December 2018

The functional assessment of patients with non-obstructive coronary artery disease: Expert review from an international microcirculation working group.

EuroIntervention 2018 Dec 18. Epub 2018 Dec 18.

Mayo Clinic Department of Cardiovascular Medicine, Rochester, MN, USA.

Coronary artery disease (CAD) is a leading cause of morbidity and mortality worldwide, and symptomatic non-obstructive CAD (NOCAD) is an increasingly recognized entity that is associated with poor cardiovascular outcomes. Nearly half of those undergoing coronary angiography for appropriate indications such as typical angina or a positive stress test have no obstructive lesion. Physiologic assessment of the coronary arteries beyond the two-dimensional angiography is not standardized, yet can provide valuable information in such patients presenting with typical angina in the setting of NOCAD. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00982DOI Listing
December 2018

Influence of Target Vessel on Prognostic Relevance of Fractional Flow Reserve After Coronary Stenting.

EuroIntervention 2018 Dec 18. Epub 2018 Dec 18.

Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.

Aims: We sought to investigate the influence of target vessel on prognostic relevance of fractional flow reserve (FFR) after percutaneous coronary intervention (PCI).

Methods And Results: A total of 835 patients with available FFR after 2nd generation drug-eluting stent (DES) implantation were included in this study. The primary outcome was target-vessel failure (TVF), including cardiac death, target-vessel related myocardial infarction, and clinically-driven target-vessel revascularization. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00913DOI Listing
December 2018

Personalised Fractional Flow Reserve: Novel Concept to Optimise Myocardial Revascularization.

EuroIntervention 2018 Dec 18. Epub 2018 Dec 18.

Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, United Kingdom.

Aims: Fractional flow reserve (FFR) represents the percentage reduction in coronary flow relative to a hypothetically normal artery, but percutaneous coronary intervention (PCI) seldom achieves physiological normality (FFR 1.00), particularly in the context of diffuse disease. We describe a method for calculating the vessel-specific maximal achievable FFR (FFRmax) providing a personalised assessment of what PCI can achieve. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00668DOI Listing
December 2018

A golden age for interventional cardiology as patient-centred care emerges from our technical preoccupations.

Authors:
Martine Gilard

EuroIntervention 2018 Dec 7;14(11):e1166-e1167. Epub 2018 Dec 7.

CHU La Cavale Blanche, Brest, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJV14I11A211DOI Listing
December 2018
1 Read

Percutaneous revascularisation of chronic occluded coronaries - availability of the retrograde approach increases technical success and the quality of life despite more frequent complications.

Authors:
Julinda Mehilli

EuroIntervention 2018 Dec 7;14(11):e1163-e1165. Epub 2018 Dec 7.

Department of Cardiology, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJV14I11A210DOI Listing
December 2018

PCI in TAVI patients: who, why and when?

EuroIntervention 2018 Dec 7;14(11):e1160-e1162. Epub 2018 Dec 7.

Cardiovascular Department, King's College London, St Thomas' Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJV14I11A209DOI Listing
December 2018

The invisible army of women in interventional cardiology: EAPCI Women mission to make them visible.

EuroIntervention 2018 Dec 7;14(11):e1158-e1159. Epub 2018 Dec 7.

Department of Cardiology, North Cumbria University Hospitals NHS Trust, Carlisle, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJV14I11A208DOI Listing
December 2018

Quo vadis, aspirin?

Authors:
Davide Capodanno

EuroIntervention 2018 Dec 7;14(11):e1153-e1157. Epub 2018 Dec 7.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJV14I11A207DOI Listing
December 2018
1 Read

Transcatheter Tricuspid Valve Replacement for Pacemaker-Associated Tricuspid Regurgitation.

EuroIntervention 2018 Dec 11. Epub 2018 Dec 11.

Division of Cardiology, St Michael's Hospital, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00970DOI Listing
December 2018
1 Read

Double kissing mini-culotte versus mini-culotte stenting: insights from micro-computed tomographic imaging of bench testing.

EuroIntervention 2018 Dec 11. Epub 2018 Dec 11.

Department of Cardiology, Union Hospital, Fujian Medical University, Fuzhou, China.

Aims: This study aimed to evaluate the morphologic characteristics of double kissing mini-culotte (DK-mini-culotte) and mini-culotte stenting through imaging of bench testing.

Methods And Results: DK-mini-culotte and mini-culotte stenting were performed in two silicone bifurcated phantoms with branch vessel diameter differences of 0.5 mm (Model 1) and 1. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00688DOI Listing
December 2018
1 Read

Transcatheter Aortic Valve Implantation (TAVI) in Germany: Surpassing >100,000 procedures and now Standard of Care for the Elderly.

EuroIntervention 2018 Dec 11. Epub 2018 Dec 11.

Cardioangiologisches Centrum Bethanien (CCB) and Agaplesion Bethanien Hospital, Frankfurt, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-01010DOI Listing
December 2018
1 Read

Management of Incomplete Surgical Left Atrial Appendage Exclusion.

EuroIntervention 2018 Nov 27. Epub 2018 Nov 27.

Division of Cardiology, Department of Medicine, West Virginia University, Morgantown, WV, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-01064DOI Listing
November 2018
1 Read

Impact of implant depth on hydrodynamic function with the ACURATE neo transcatheter heart valve following valve-in-valve transcatheter aortic valve replacement in Mitroflow bioprosthetic valves: an ex-vivo bench study.

EuroIntervention 2018 Nov 27. Epub 2018 Nov 27.

Center for Heart Valve Innovation, St Paul's Hospital, University of British Colombia, Vancouver, Canada.

Aims: We assessed impact of implant depth on hydrodynamic function following valve-in-valve(VIV) transcatheter aortic valve replacement(TAVR) using the ACURATE neo (Boston Scientific Corporation, Natick, MA) transcatheter heart valve(THV) through an ex-vivo bench study.

Methods And Results: Multiple implantation depths were tested at incremental depths of 2mm using a small size ACURATE neo valve for VIV TAVR in 19mm, 21mm, 23mm, and 25mm Mitroflow(Sorin Group Canada Inc, Burnaby, BC) bioprosthetic valves. Multimodality imaging and hydrodynamic evaluation was performed at each implantation depth. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00947DOI Listing
November 2018
1 Read

Joint consensus on the use of OCT in coronary bifurcation lesions by European and Japanese bifurcation clubs.

EuroIntervention 2018 Nov 27. Epub 2018 Nov 27.

ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands.

Coronary artery bifurcation lesions comprise approximately 15-20% of all PCI and constitute a complex lesion subgroup. Intravascular optical coherence tomography (OCT) is a promising adjunctive tool for guiding coronary bifurcation with its unrivalled high resolution. Compared to angiography, intravascular OCT has a clear advantage to depict ostial lesion(s) in bifurcation without misleading 2-dimensional appearance of the conventional angiography such as overlap and foreshortening. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00391DOI Listing
November 2018
2 Reads

Patient Focus in Interventional Cardiology: the EAPCI Initiative.

Authors:
Andreas Baumbach

EuroIntervention 2018 Nov;14(10):1087

Queen Mary University London (QMUL) and Barts Heart Centre, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJV14I10A196DOI Listing
November 2018
1 Read

Women and ischaemic heart disease: treat her like a lady!

Authors:
Angela Maas

EuroIntervention 2018 Nov;14(10):1084-1086

Department of Cardiology, Radboudumc, Nijmegen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJV14I10A195DOI Listing
November 2018
2 Reads

Optical coherence tomography revisited: imaging and imagination.

EuroIntervention 2018 Nov;14(10):1080-1083

Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJV14I10A194DOI Listing
November 2018
2 Reads

The evolution of PCI registries: implementing a sustainable future for health systems and clinicians.

EuroIntervention 2018 Nov;14(10):1076-1079

The Duke Clinical Research Institute, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://www.pcronline.com/eurointervention/143rd_issue/193
Publisher Site
http://dx.doi.org/10.4244/EIJV14I10A193DOI Listing
November 2018
4 Reads

Transradial left main PCI is safe and effective.

EuroIntervention 2018 Nov;14(10):1073-1075

Department of Medicine, McMaster University and Population Health Research Institute, Hamilton Health Sciences, Hamilton, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJV14I10A192DOI Listing
November 2018
1 Read

Drug-coated balloons versus drug-eluting stents for in-stent restenosis: the saga continues.

EuroIntervention 2018 Nov;14(10):1069-1072

Department of Cardiology, Hospital Universitario de La Princesa, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJV14I10A191DOI Listing
November 2018
1 Read

The ESC Congress 2018 and the legacy of Eugene Braunwald.

Authors:
Robert A Byrne

EuroIntervention 2018 Nov;14(10):1067-1068

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJV14I10A190DOI Listing
November 2018
1 Read

Intravascular assessment of coronary arteries in patients with cyanotic congenital heart disease.

EuroIntervention 2018 Nov 20. Epub 2018 Nov 20.

Department of Cardiology, Rigshospitalet, University of Copenhagen, Denmark.

Aims: Patients with cyanotic congenital heart disease (CCHD) have been suggested to develop less atherosclerosis than the general population. This study aimed to evaluate the extent of coronary atherosclerosis in patients with CCHD using intravascular ultrasound (IVUS) and near-infrared spectroscopy (NIRS).

Methods And Results: Fifteen patients with CCHD (women, 9; median age, 53 years) and 14 acyanotic controls (women, 6; median age, 53 years) were examined with IVUS-NIRS of the right coronary artery (RCA). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00882DOI Listing
November 2018
3 Reads

ImpellaCP or VA-ECMO in profound cardiogenic shock: left ventricular unloading and organ perfusion in a large animal model.

EuroIntervention 2018 Nov 13. Epub 2018 Nov 13.

Department of cardiology, cardiothoracic surgery and intensive care, Odense University Hospital, Denmark.

Aims/ To evaluate ImpellaCP over Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) and their impact on left ventricular (LV) unloading and end-organ perfusion. Methods and results: cardiogenic shock (CS) was induced by injecting microspheres into the left coronary artery in fourteen adult female swine. ImpellaCP or VA-ECMO was initiated in the presence of CS and evaluated after 60 minutes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00684DOI Listing
November 2018
2 Reads

Prosthesis-Patient Mismatch after Transcatheter Aortic Valve Implantation: Prevalence and Prognostic Impact under Consideration of Baseline Left Ventricular Function.

EuroIntervention 2018 Nov 13. Epub 2018 Nov 13.

Department of General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany.

Aims: We aimed to assess prevalence and features of PPM following transcatheter aortic valve implantation (TAVI) and its prognostic impact considering baseline left ventricular ejection fraction (LVEF).

Methods And Results: Data from 1,309 patients undergoing TAVI for severe aortic stenosis was derived from a single-center dedicated TAVI registry. PPM was assessed according to echocardiography at discharge and was defined in accordance with VARC2. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00827DOI Listing
November 2018
1 Read

Intracoronary Tenecteplase versus Abciximab as Adjunctive Treatment during Primary Percutaneous Coronary Intervention in Patients with Anterior Myocardial Infarction.

EuroIntervention 2018 Nov 13. Epub 2018 Nov 13.

Department of Cardiology, Puerto Real Universitary Hospital, Cadiz, Spain.

Aims: We sought to compare the effects of intracoronary administration of a fibrinolytic drug (tenecteplase) to those of a glycoprotein IIb/IIIa inhibitor (abciximab) in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI).

Methods And Results: In this pilot trial, 76 patients (59 male) with anterior STEMI were randomised to intracoronary infusion of reduced-dose tenecteplase or abciximab during PPCI. Angiography was repeated at 48 hours to assess corrected TIMI frame count (cTFC) and TIMI myocardial perfusion grade (TMPG). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00885DOI Listing
November 2018
3 Reads

Early outcomes of percutaneous pulmonary valve implantation using the Edwards SAPIEN 3 transcatheter heart valve system.

EuroIntervention 2018 Nov 13. Epub 2018 Nov 13.

Hôpital Marie Lannelongue, Le Plessis Robinson, France.

Aims: Multiple surgical revisions are often necessary in individuals with congenital heart defects affecting the RVOT or pulmonary valve. There are no multicentre data on the feasibility and safety of percutaneous pulmonary valve implantation using the SAPIEN 3 (S3) transcatheter heart valve.

Methods And Results: Pulmonic S3 is an observational registry of patients undergoing PPVI with the S3 valve across centres in Europe and Canada. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-01035DOI Listing
November 2018
2 Reads
3.770 Impact Factor

A new practical anatomical classification for left atrial appendage closure (LAAC).

EuroIntervention 2018 Nov 6. Epub 2018 Nov 6.

Centro Medico Docente la Trinidad, Caracas, Venezuela.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00512DOI Listing
November 2018
1 Read

Impact of Absorb bioresorbable scaffold implantation technique on post-procedural quantitative coronary angiographic endpoints in ST-elevation myocardial infarction: a sub-analysis of the BVS STEMI STRATEGY-IT study.

EuroIntervention 2018 Nov 6. Epub 2018 Nov 6.

Cardiovascular institute, Department of Cardiology, Hospital Clínic, Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Aims: To evaluate the impact of bioresorbable vascular scaffold (BRS) implantation technique on post-procedural quantitative coronary angiography (QCA) parameters in ST-elevation myocardial infarction (STEMI).

Methods And Results: We assessed 442 STEMI patients who underwent BRS implantation in the BVS STEMI STRATEGY-IT study. Optimal BRS implantation was assessed using PSP-score, developed and validated in the GHOST-EU registry. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00504DOI Listing
November 2018
9 Reads

How does the failure of Absorb apply to the other bioresorbable scaffolds?: Expert review of first-in-man and pivotal trials.

EuroIntervention 2018 Nov 6. Epub 2018 Nov 6.

Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.

Absorb bioresorbable scaffold (BRS), the most studied device among all BRS, suffered a major setback following the negative results of the ABSORB trials. However, approximately 34 BRSs from 22 companies are currently under development. The potential device specific factors related to increased event rate in Absorb were: 1) weaker mechanical properties, 2) larger strut thickness (less embedment and larger protrusion) and width (larger footprint) predisposing to underexpansion / protrusion of strut, eventually resulting in increased thrombogenicity, and 3) longer bioresorption time combined with failure of encapsulation of struts before dismantling process ensues. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00607DOI Listing
November 2018
5 Reads
3.770 Impact Factor

Impact of the 1-year angioscopic findings on long-term clinical events in 504 patients treated with first-generation or second-generation drug-eluting stents: The DESNOTE-X Study.

EuroIntervention 2018 Nov 6. Epub 2018 Nov 6.

Department of Cardiology, Osaka Police Hospital, Osaka, Japan.

Aims: We aimed to test the hypothesis that presence of in-stent yellow plaque (YP) assessed by angioscopy would be a risk of very late stent failure (VLSF) of the cobalt chromium everolimus-eluting stent (CoCr-EES) in comparison with first-generation drug-eluting stents (DES).

Methods And Results: The DESNOTE-X study was a prospective cohort study, an extended study of the DESNOTE (UMIN000013515). All patients who received successful angioscopic examination at planned 1-year follow-up of DES were clinically followed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00660DOI Listing
November 2018
6 Reads

A self-expanding percutaneous valve for patients with pulmonary regurgitation and an enlarged native right ventricular outflow tract: one-year results.

EuroIntervention 2018 Nov 6. Epub 2018 Nov 6.

Zhongshan Hospital of Fudan University, Shanghai, China.

Aims: To assess the safety and efficacy of the Venus p-valve.

Methods And Results: Patients who had moderate or severe pulmonary regurgitation after surgical repair of the right ventricular outflow tract (RVOT) with a transannular or RVOT patch were included in the study. Fifty-five patients (67% female; average age 28. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00715DOI Listing
November 2018
9 Reads

Single Lobe Left Atrial Appendage with Large Ostia Anatomy: Implications for Kissing-Watchman Technology.

EuroIntervention 2018 Nov 6. Epub 2018 Nov 6.

Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, Shaanxi, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00870DOI Listing
November 2018
2 Reads

Clipping within the leaflet - a novel approach to complex mitral regurgitation pathologies.

EuroIntervention 2018 Oct 30. Epub 2018 Oct 30.

Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00772DOI Listing
October 2018
1 Read

A Randomised Controlled Trial to Compare two Coronary Pressure Wires using Simultaneous Measurements in Human Coronary Arteries The COMET trial.

EuroIntervention 2018 Oct 30. Epub 2018 Oct 30.

Institute of Cardiovascular Medicine and Science, Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, United Kingdom.

Aims: We examined the relative performance of the new COMET wire from Boston Scientific (BS), and the established technology from St Jude/Abbott Vascular (SJ).

Methods And Results: We compared simultaneous readings from pairs of wires. Patients were randomised to one of three groups, BS/BS; SJ/SJ; SJ/BS. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00786DOI Listing
October 2018
1 Read

Thromboresistance and Functional Healing in the COBRA PzF Stent versus Competitor DES: Implications for Dual Anti-Platelet Therapy.

EuroIntervention 2018 Oct 30. Epub 2018 Oct 30.

CVPath Institute Inc, Gaithersburg, MD, USA.

Aims: To investigate the COBRA-PzF stent (C-PzF) with respect to thrombogenicity and healing versus conventional drug-eluting stents (DES) in dedicated preclinical models to evaluate their suitability for short-term dual anti-platelet therapy (DAPT).

Methods And Results: To examine acute thrombogenicity, C-PzF, durable polymer drug-eluting stent (DP-DES), and bioabsorable polymer DES (BP-DES) were compared in a porcine arteriovenous shunt model and in a rabbit model to evaluate endothelial coverage at 14 days. Barrier function at 28 days in the rabbit was assessed in the former stents as well as in polymer free DES (PF-BES). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00740DOI Listing
October 2018
6 Reads

Very long-term outcome of coronary covered stents. A report from the SCAAR registry.

EuroIntervention 2018 Oct 30. Epub 2018 Oct 30.

Department of Coronary Heart Disease and Institution of Clinical Sciences, Lund University, Sweden.

Aims: To elucidate the short and long-term outcome of patients treated with covered stents compared to all other stented patients. Covered stents are mostly used for coronary perforations with high risk of early adverse events, but their long-term outcome are unknown.

Methods And Results: The Swedish national registries from 2005 - 2017 disclosed 265 patients receiving 366 covered stents. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00855DOI Listing
October 2018
6 Reads

Transcatheter Aortic Valve Implantation using ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity matched analysis of an European experience.

EuroIntervention 2018 Oct 30. Epub 2018 Oct 30.

Interventional Cardiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Aims: to assess the performance of a self-expandable valve in bicuspid aortic valves (BAV) stenosis.

Method And Results: an international multicentre registry included a total of 712 patients with aortic stenosis treated with ACURATE neo in both bicuspid (n=54%; 7.5%) or tricuspid (n=658; 92,4%) anatomy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00281DOI Listing
October 2018
14 Reads
3.770 Impact Factor

Predictors of Long-term Adverse Events After Absorb Bioresorbable Vascular Scaffold Implantation: A 1,933-Patient Pooled Analysis From International Registries.

EuroIntervention 2018 Oct 30. Epub 2018 Oct 30.

Hospital Israelita Albert Einstein, São Paulo, Brazil.

Aims: To investigate the predictors of long-term adverse clinical events after implantation of the everolimus-eluting Absorb bioresorbable vascular scaffold (BVS).

Methods And Results: We pooled patient-level databases derived from the large-scale ABSORB EXTEND study and five high-volume international centers. Between November 2011 and November 2015, 1,933 patients underwent PCI with a total of 2,372 Absorb BVS implanted. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-16-00796DOI Listing
October 2018
13 Reads
3.770 Impact Factor

Retrograde Approach for Percutaneous Recanalization of Coronary Chronic Total Occlusions; Contribution to Clinical Practice and Its Long-term Results.

EuroIntervention 2018 Oct 30. Epub 2018 Oct 30.

Division of Cardiology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Asan Medical Center, Seoul Korea.

Aims: We evaluated the contribution of the retrograde approach to real-world practice over time and its long-term outcomes in chronic total occlusion (CTO)-percutaneous coronary intervention (PCI).

Methods And Results: We evaluated 1,635 CTO procedures conducted at our high-volume center between 2003 and 2015. The retrograde approach has been actively adopted in practice since January 2007. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00538DOI Listing
October 2018
7 Reads

Clinical outcomes of bioresorbable vascular scaffolds implanted with routine versus selective optical coherence tomography guidance: results from a single-center experience.

EuroIntervention 2018 Oct 30. Epub 2018 Oct 30.

Department of Interventional Cardiology, Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom.

Aims: We investigated the effects of an initial learning period with mandatory optical coherence tomography (OCT) guidance for the implantation of everolimus-eluting bioresorbable vascular scaffolds (BVS).

Methods And Results: We analyzed procedural and clinical outcomes of all BVS implantations at a single center where OCT guidance was mandatory in the initial rollout (OCT-mandatory) phase. We compared these data with the later phase where use of OCT was at operator discretion (OCT-selective or angiography). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJ-D-18-00262DOI Listing
October 2018
6 Reads

Transcatheter aortic valve looking for low-risk patients: a post hoc analysis of SURTAVI keeps opening the door.

Authors:
Rodrigo Bagur

EuroIntervention 2018 Oct;14(8):846-848

London Health Sciences Centre, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJV14I8A151DOI Listing
October 2018